Recent health changes due to the development of PDAC were evident in several risk factors we investigated: acute and chronic pancreatitis, abdominal pain, jaundice, DPP-IV inhibitor use, the recent onset of which was more strongly associated than more distant diagnosis/use. The gene discussed is DPP4; the disease is chronic pancreatitis.